ARCHIVES

Fisher and Redmond Subject Of Misconduct Investigation; ORI

This article is from The Cancer Letter archive.

Vol. 20 No. 18 | May 6, 1994

Download PDF Visit The Full Archive

Related Articles

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

January 29, 2010

Axitinib Shows Activity Against Advanced Thyroid Cancer

July 27, 2007

Nexon Heads Kennedy Committee Health Staff: Pepper Introduces Bill For May As “NCI Month”

January 16, 1987

Cooperative Groups Get Reprieve From Cut As Budget Is Flatlined At Fiscal 2006 Level.

June 8, 2007

Wistar Investigators Report Oncogene Relation to Burkitt’s

November 26, 1982

FDA Invites Ad Hoc Consumer Reps To ODAC Meetings

February 17, 1995